Volume 14, Number 6—June 2008
Land Use and West Nile Virus Seroprevalence in Wild Mammals
Highlight and copy the desired format.
|EID||Gómez A, Kilpatrick A, Kramer LD, Dupuis AP, Maffei JG, Goetz SJ, et al. Land Use and West Nile Virus Seroprevalence in Wild Mammals. Emerg Infect Dis. 2008;14(6):962-965. https://dx.doi.org/10.3201/eid1406.070352|
|AMA||Gómez A, Kilpatrick A, Kramer LD, et al. Land Use and West Nile Virus Seroprevalence in Wild Mammals. Emerging Infectious Diseases. 2008;14(6):962-965. doi:10.3201/eid1406.070352.|
|APA||Gómez, A., Kilpatrick, A., Kramer, L. D., Dupuis, A. P., Maffei, J. G., Goetz, S. J....Aguirre, A. A. (2008). Land Use and West Nile Virus Seroprevalence in Wild Mammals. Emerging Infectious Diseases, 14(6), 962-965. https://dx.doi.org/10.3201/eid1406.070352.|
We examined West Nile virus (WNV) seroprevalence in wild mammals along a forest-to-urban gradient in the US mid-Atlantic region. WNV antibody prevalence increased with age, urbanization, and date of capture for juveniles and varied significantly between species. These findings suggest several requirements for using mammals as indicators of transmission.
West Nile virus (WNV) is maintained in an enzootic bird-mosquito-bird cycle and is transmitted by numerous mosquito species, including many that feed on mammals (1). Several mammal species have been found to be naturally exposed to WNV, and it has been suggested that wild mammals could be used as indicators of transmission (2–4). WNV seroprevalence in wild mammals will be a useful indicator of WNV activity only if it differs between sites, if it reflects within-season transmission, and if other key confounding factors are accounted for.
To test 4 hypotheses about the exposure of mammals to WNV, we examined WNV seroprevalence in wild mammals in the eastern United States. First, we predicted that WNV seroprevalence would differ significantly among species because of differences in mosquito preferences, mammal behavior and survival, and other factors (2,3). Second, we predicted that seroprevalence would be higher for adults than for juveniles because adults have been exposed to WNV for at least 1 additional year. Third, we predicted that WNV exposure would increase with the date of capture over the transmission season because peak transmission occurs during late summer. Finally, we predicted that WNV seroprevalence would vary among sites and increase with urbanization because the abundance of Culex pipiens, the dominant enzootic vector in this region (1), increases with human population density (4).
We trapped mammals at 7 sites along a forest-to-urban gradient in Maryland and Washington, DC, USA, from early June to late September 2005 and in April 2006. The sites included 1 forested area (Smithsonian Environmental Research Center, Edgewater, MD), 2 large wooded parks (Rock Creek Park, Rockville, MD; Fort Dupont Park, Washington, DC), 2 residential neighborhoods (Takoma Park, MD; Bethesda, MD), and 2 urban areas (Baltimore, MD; Washington, DC).
We quantified the land use around each site by calculating an urbanization index (UI) within a 1,000-m radius as follows:
Impervious land and forest cover were estimated by using multitemporal (leaf-on and leaf-off) compilations of Landsat satellite images at 30-m spatial resolution, higher resolution satellite imagery, and digital orthophotography (5).
We ran trap lines of Tomahawk (models 201, 203, 204, 207; Tomahawk Live Trap Company, Tomahawk, WI, USA) and Sherman (model LFAHD; H.B. Sherman Traps, Inc., Tallahassee, FL, USA) traps for 2–5 days and nights at each site. Captured animals were chemically restrained and tagged, and age was determined by using body mass and/or reproductive characters (6). Blood samples (0.1 mL) were obtained, dispensed into tubes containing 0.9 mL BA-1 medium, and placed on ice packs until storage at –80°C. Blood samples were allowed to clot before antibody assays were run. We assayed the blood samples for neutralizing antibodies to WNV and Powassan virus (but not St. Louis encephalitis virus, which was absent in the local bird community at these sites ) by using the plaque-reduction neutralization test (8) at a 1:10 dilution, with 80% and 90% neutralization of plaques as cutoffs. We examined variation in WNV antibody prevalence by using binary logistic regression with species and age as categorical factors and capture date and urbanization index as covariates. We used October 15, 2005, as the capture date for the April 2006 samples because the abundance of WNV-infected mosquitoes falls precipitously after this date (9).
We obtained 244 samples from 11 mammal species (Table 1). The probability of being WNV antibody–positive varied significantly among species, was significantly higher for adults, increased with capture date for juveniles, and increased with the urbanization index (Table 2). The higher seroprevalence in samples collected in April 2006 showed that WNV exposure of juvenile eastern gray squirrels (Sciurus carolinensis) continued after the last trapping periods in September 2005 (Table 2).
Seroprevalence rates were highest (and not significantly different) in 4 peridomestic species: eastern gray squirrels, Virginia opossums (Didelphis virginiana), raccoons (Procyon lotor), and Norway rats (Rattus norvegicus) (Tables 1, 2). Eastern gray squirrels were 5.5× more likely than eastern chipmunks (Tamias striatus) to have WNV antibodies and 4.5× more likely than Peromyscus leucopus; both differences were significant (Table 2).
Previous research on the exposure of mammals to WNV has shown patterns of antibody prevalence across several states and species (2,3,10–12). However, few studies have tested for statistical differences in the factors that influence the exposure of mammals to WNV, which thus would establish their usefulness as indicators of variation in WNV transmission. We found significant effects of age, species, site, and date of capture on WNV seroprevalence.
The increase in seroprevalence with urbanization suggests that factors that increase WNV transmission, including mosquito abundance, WNV prevalence, or feeding on mammals, are higher in more urban areas. However, increased survival of mammals in urban areas could also result in increased seroprevalence associated with urbanization.
As in other studies, we found high WNV seroprevalence in 3 common peridomestic wild mammal species (D. virginiana, P. lotor, and S. carolinensis) and lower seroprevalence in T. striatus (Table 1) (3,11,12). Fatal WNV infection or low mosquito exposure for T. striatus could account for low seroprevalence in this species in areas where other species were often exposed (Table 1) (7,9,13). Additionally, we found that prevalence was significantly lower in juvenile P. leucopus in forested areas than in urbanized areas (Table 1; 0/11 vs. 2/3; Fisher exact test p = 0.032), which might explain some of the site variability found in previous studies (3). Finally, we found higher seroprevalence in rats than did previous studies (3) (4/7 vs. 2/36 ; Fisher exact test p = 0.004), which may have been a result of sampling rats from highly urban areas.
In addition to host death and spatial variation in prevalence and vector abundance, vector feeding preferences may also contribute to the observed variability in WNV seroprevalence. Previous studies have shown that WNV vectors do feed on S. carolinensis, P. lotor, and D. virginiana (14,15), but these studies do not show data on host abundance, so feeding preferences cannot be determined. Similarly, at our sites several mammal species, including S. carolinensis and D. virginiana, were sources of Cx. pipiens blood meals (7). Unfortunately, sample sizes of blood meals that came from mammalian hosts were too small for determining relative preferences for different mammals, and most species (except S. carolinensis) are at low enough abundances that substantial numbers of blood meals would be required to estimate feeding preferences. Mosquito preferences for different mammal species is an area for future research.
In our study, the probability of having WNV antibodies increased with capture date for juveniles but not for adults (Table 2), which suggests that juveniles experience higher exposure and would be more useful for WNV monitoring. Higher exposure of juveniles may result from increased attractiveness to mosquitoes or weaker defensive behavior.
Mammals have been proposed as sentinels for human WNV risk because infection would indicate transmission outside the enzootic bird cycle (3). Our study demonstrates that wild mammals satisfy 2 critical requirements: spatial and temporal variability in exposure. Our results also show that to estimate current year transmission at the site of capture, using wild mammals as sentinels will require adequate samples of young animals that year or a longitudinal approach (10). Our finding that mammalian WNV seroprevalence appears to be more intense in urban areas suggests that per capita risk for exposure is higher in these areas.
Mr Gómez is a PhD candidate at Columbia University’s Department of Ecology, Evolution, and Environmental Biology. His research interests include the effects of environmental change on the ecology of infectious diseases and conservation biology.
We thank the field crews; the participants of Neighborhood Nestwatch and other residents; and the staff of the parks, museums, and the Smithsonian Environmental Research Center for permission to use their properties.
This work was funded by the National Institute of Allergy and Infectious Diseases contract no. NO1-AI-25490, grant no. 2003-0209-000 from the National Fish and Wildlife Foundation, National Science Foundation grant EF-0622391 as part of the joint National Science Foundation–National Institutes of Health Ecology of Infectious Disease program, the V. Kann Rasmussen Foundation, a Columbia University Graduate School of Arts and Sciences Faculty Fellowship, and the Whitley Fund for Nature. S.J.G. acknowledges support from National Aeronautics and Space Administration’s Applied Sciences and Land Cover Land Use Change programs.
- Kilpatrick AM, Kramer LD, Campbell SR, Alleyne EO, Dobson AP, Daszak P. West Nile virus risk assessment and the bridge vector paradigm. Emerg Infect Dis. 2005;11:425–9.
- Dietrich G, Montenieri JA, Panella NA, Langevin S, Lasater SE, Klenk K, Serologic evidence of West Nile virus infection in free-ranging mammals, Slidell, Louisiana, 2002. Vector Borne Zoonotic Dis. 2005;5:288–92.
- Root JJ, Hall JS, McLean RG, Marlenee NL, Beaty BJ, Gansowski J, Serologic evidence of exposure of wild mammals to flaviviruses in the central and eastern United States. Am J Trop Med Hyg. 2005;72:622–30.
- Andreadis TG, Anderson JF, Vossbrinck CR, Main AJ. Epidemiology of West Nile virus in Connecticut: a five-year analysis of mosquito data 1999–2003. Vector Borne Zoonotic Dis. 2004;4:360–78.
- Goetz SJ, Jantz CA, Prince SD, Smith AJ, Wright R, Varlyguin D. Integrated analysis of ecosystem interactions with land use change: the Chesapeake Bay watershed. In: DeFries RS, Asner GP, Houghton RA, editors. Ecosystems and land use change. Washington: American Geophysical Union; 2004. p. 263–75.
- Kunz TH, Wemmer C, Hayssen V. Sex, age and reproductive condition of mammals. In: Wilson DE, Russell Cole F, Nichols JD, Rudran R, Foster MS, editors. Measuring and monitoring biological diversity standard methods for mammals. Washington: Smithsonian Institution Press; 1996.
- Kilpatrick AM, Daszak P, Jones MJ, Marra PP, Kramer LD. Host heterogeneity dominates West Nile virus transmission. Proc R Soc Lond B Biol Sci. 2006;273:2327–33.
- Calisher CH, Karabatsos N, Dalrymple JM, Shope RE, Porterfield JS, Westaway EG, Antigenic relationships between flaviviruses as determined by cross-neutralization tests with polyclonal antisera. J Gen Virol. 1989;70:37–43.
- Kilpatrick AM, Kramer LD, Jones MJ, Marra PP, Daszak PBB. West Nile virus epidemics in North America are driven by shifts in mosquito feeding behavior. PLoS Biol. 2006;4:e82–10.
- Root JJ, Oesterle PT, Sullivan HJ, Hall JS, Marlenee NL, McLean RG, Short report: fox squirrel (Sciurus niger) associations with West Nile virus. Am J Trop Med Hyg. 2007;76:782–4.
- Docherty DE, Samuel MD, Nolden CA, Egstad KF, Griffin KM. West Nile virus antibody prevalence in wild mammals, Wisconsin. Emerg Infect Dis. 2006;12:1982–4.
- Bentler KT, Hall JS, Root JJ, Klenk K, Schmit B, Blackwell BF, Serologic evidence of West Nile virus exposure in North American mesopredators. Am J Trop Med Hyg. 2007;76:173–9.
- Platt KB, Tucker BJ, Halbur PG, Tiawsirisup S, Blitvich BJ, Fabiosa FG, West Nile virus viremia in eastern chipmunks (Tamias striatus) sufficient for infecting different mosquitoes. Emerg Infect Dis. 2007;13:831–7.
- Molaei G, Andreadis TA, Armstrong PM, Anderson JF, Vossbrinck CR. Host feeding patterns of Culex mosquitoes and West Nile virus transmission, northeastern United States. Emerg Infect Dis. 2006;12:468–74.
- Hamer GL, Kitron UD, Brawn JD, Loss SR, Ruiz MO, Goldberg TL, Culex pipiens (Diptera:Culicidae): a bridge vector of West Nile virus to humans. J Med Entomol. 2008;45:125–8.
- Table 1. West Nile virus in wild mammals at 7 sites in Washington, DC, and Maryland, United States
- Table 2. Logistic regression analysis of West Nile virus seroprevalence in wild mammals
Please use the form below to submit correspondence to the authors or contact them at the following address:
Andrés Gómez, Department of Ecology, Evolution, and Environmental Biology, Columbia University, 1200 Amsterdam Ave, MC5557, New York, NY 10027, USA;
Comment submitted successfully, thank you for your feedback.
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
- Page created: July 09, 2010
- Page last updated: July 09, 2010
- Page last reviewed: July 09, 2010
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)